Aripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb; Otsuka America Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 13 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.